Conference Call │ Q1/21 Results
Bad Homburg, 06 May 2021
Safe Harbor Statement
This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing.
Fresenius does not undertake any responsibility to update the forward-looking statements contained in this presentation.
Q1/21 Results, 06 May 2021 © Fresenius SE & Co. KGaA Investor Relations & Sustainability | 2 |
Agenda
01
Key messages
02 | 03 | 04 | ||
Strategic update | Financial review | Outlook FY/21 | ||
Q1/21 | ||||
Q1/21 Results, 06 May 2021 © Fresenius SE & Co. KGaA Investor Relations & Sustainability | 3 |
Key messages
Good start to the year; | Ongoing decisive efforts to | Cost & efficiency program: | Guidance FY/21 confirmed | |||||||||
robust growth rates despite | combat COVID-19 | Savings of at least €100 m | ||||||||||
tough prior year comp | p.a. after tax and minorities | |||||||||||
in 2023 | ||||||||||||
Delivers solid first quarter in | Ongoing headwinds in North | Elective treatments in | Q1/21 significantly | ||||
light of COVID-19 pandemic | America whilst Emerging | Germany still on low level; | impacted by COVID-19 | ||||
Markets show healthy | activity levels in Spain | ||||||
growth | higher than pre-pandemic | ||||||
levels | |||||||
Q1/21 Results, 06 May 2021 © Fresenius SE & Co. KGaA Investor Relations & Sustainability | 4 | ||||||
Agenda
01
Key messages
02
Strategic update
03 | 04 | |
Financial review | Outlook FY/21 | |
Q1/21 | ||
Q1/21 Results, 06 May 2021 © Fresenius SE & Co. KGaA Investor Relations & Sustainability | 5 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Fresenius SE & Co. KGaA published this content on 10 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 May 2021 14:25:04 UTC.